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The Harderian gland is a compound tubulo-alveolar 
apocrine gland, located in each orbit, posterior to the 
eyeball. These glands were discovered in 1864 by the 
celebrated Swiss physician, Johann Jacob Harder, and 
they have been found in those animals possessing a 
membrana nictitans [l] ; it is thought that the function 
of the secretion is to lubricate this “third eyelid”. The 
first studies of the amorphous pigment in the Harderian 
glands were made by Derrien and Turchini in 1924 
[2] using albino and piebald rats, and they identified 
this pigment as a porphyrin, The solubility and spec- 
troscopic properties of this porphyrin were very simi- 
lar to those of the porphyrin of egg-shells and the 
Kammerer porphyrin, which were subsequently shown 
to be protoporphyrin-IX by Fischer [3] . Many later 
workers confirmed the presence of protoporphyrin in 
the glands, and much of the more recent work has 
been concerned with the possible relationship between 
porphyrin biosynthesis in the glands, and the suscep- 
tibility of the animals to cancer. 
In 1954, one of us (G.Y.K.) showed that a tricar- 
boxylic porphyrin is also present in the glands of nor- 
mal rats. He subsequently showed that the glands are 
normally capable of synthesising porphyrin [4] , and 
this was later confirmed by other workers, notably 
Davidheiser and Figge [5], and more recently by Tomio 
* Present address: Department of Chemistry, University Col- 
lege, Cathays Park, Cardiff. 
North-Holland Publishing Company - Amsterdam 
and Grinstein [6] . We have now isolated the pure 
compound which we name, Harderoporphyrin, and we 
have defined its structure as (Ia). 
In the present work, the porphyrin esters obtained 
by the extraction of the glands of normal Wistar rats 
with methanol containing 5% v/v sulphuric acid have 
been separated into two fractions by column chrom- 
atography on magnesium oxide (Grade III) in chloro- 
form. The main band, eluted first, was protoporphy- 
rin-IX dimethyl ester, whilst the second band (the 
Harderoporphyrin) eluted with chloroform contaning 
0.5% v/v methanol, was shown to be the trimethyl 
ester of a tricarboxylic porphyrin by paper and thin 
layer chromatography. The original sample of the 
Harderoporphyrin trimethyl ester obtained in this 
way had m.p. 151”C, and its acid number was 6.5, 
which is higher than that of protoporphyrin dimethyl 
ester (5.5). The electronic absorption spectrum in 
chloroform (&,,.406,508,542,576, 63 1 nm) was 
of the aetio type and closely resembled that of pro- 
toporphyrin dimethyl ester. On reduction with hy- 
driodic acid in glacial acetic acid a slight shift to shor- 
ter wavelengths was observed (&,,.402,506,536, 
57 1,627 nm in ether) and this shift is consistent with 
the presence of one vinyl group in the original por- 
phyrin. The absence of aldehyde or keto groups in the 
Harderoporphyrin was confirmed by the lack of reac- 
tivity towards hydroxylamine, and the absence of hy- 
droxylic substituents was demonstrated by its inert- 
ness to attempted acetylation and benzoylation. 
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Further studies of the Harderoporphyrin were car- 
ried out on material obtained both from the glands of 
normal Wistar ats, and from rats bearing the RD/3 
(Sheffield) sarcoma. The crude mixture of porphyrin 
methyl esters, extracted from the glands-of 600 nor- 
mal Wistar ats as described above, was chromato- 
graphed on thick layer plates (silica) in light petroleum 
(b.p. 60-80’)/acetone (4/l :v/v) to remove fatty ma- 
terial. All the porphyrin was then extracted from the 
plates with methylene chloride/methanol and hy- 
drolysed with methanolic potash. The mixture of free 
acids obtained was separated into three components 
by counter current distribution (100 transfers)** be- 
tween 1.3 M HzSO4 and methyl isobutyl ketone/ben- 
zene (l/l :v/v) [7] , and each of the three fractions was 
then reconverted into the corresponding methyl ester 
with methanol containing 5% v/v sulphuric acid. 
The first fraction (K = 6.49, max. at tube no. 88) 
was identified as protoporphyrin-IX, and the third 
fraction (K = 0.08 1, max. at tube no. 8) was tentati- 
vely identified as coproporphyrin-III. 
The middle fraction (K = 0.50, max. at tube no. 33) 
appeared to be a tricarboxylic porphyrin from its per 
sition in the distribution *** , and was identical with 
the Harderoporphyrin obtained in the earlier studies. 
The mass pectrum of the methyl ester showed a parent 
ion at m/e 650, and fragment ions corresponding to
the succesive loss of three CH$H$O$H, groups [8] . 
Furthermore the molecular weight and visible spec- 
trum confirmed the earlier work in showing that the 
Harderoporphyrin contained one vinyl substituent; on 
the assumption that it was closely related to protopor- 
phyrin-IX it was assigned structure (Ia) or (Ib). 
Similar results were obtained with material extrac- 
ted from the Harderian glands of 700 Wistar rats 
bearing the RD/3 (Sheffield) sarcoma, and the amounts 
of each porphyrin recovered from the glands are sum- 
marised in the table. During the course of this work 
Tomio and Grinstein [6] also showed that protopor- 
phyrin-IX, coproporphyrin-III and a tricarboxylic 
porphyrin were present in Harderian glands by paper 
chromatographic experiments. 
To distinguish between the two possibilities (Ia) and 
** The temperature was in the range 18-23OC for the dif- 
ferent runs and hance the partition coefficient varied 
slightly. 
*** Model experiments were carried out with a synthetic tri- 
carboxylic porphyrin. 
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Table 
Porphyrins obtained from rat harderian glands. 
700 Normal rats 600 rats beating 
RD/3 Sarcoma 
Yields a Relative Yields a Relative 
(mg) % b (mg) %b 
Protoporphyrin-IX 3.4 64 3.5 68 
Harderoporphyrin 1.7 29 1.1 24 
Coproporphyrin-III 0.4 9 0.6 8 
a Crystalline material isolated. 
b Relative yields estimated spectroscopically from counter 
current distribution. The total spectroscopic yield was about 
twice the amount finally obtained in crystalline form. 
(15) we have now synthesised both porphyrins by our 
recently devised b-oxobilane route [9,10], from the 
pyrromethanes (Da) and (IIb) and the o-free pyrro- 
methane (III). Transformation of the acetoxyethyl 
side-chains into vinyl groups at the porphyrin stage 
was effected by the same method as we had previously 
used [lo] for protoporphyrin-IX. The mono-vinyl 
porphyrins (Ia) and Ib) were obtained as their tri- 
methyl esters, m.p. 179-181°C and 176-178’C re- 
spectively. 
Mixed m.p. comparisons with the trimethyl ester 
of the natural material (m.p. 179’C) demonstrated 
that it was the 2-vinyl porphyrin (Ia). The mass 
spectrum of the synthetic 2-vinyl porphyrin was also 
rather more similar to that of the natural material 
than was that of the 4-vinyl isomer. However, a much 
more convincing confirmation of the structural assign- 
ment was provided by further counter current distri- 
bution experiments. A test mixture of the free acids, 
(Ia) and (Ib), derived from the two synthetic esters, 
separated partially after 600 transfers in the same 
system as before (K = 0.51 and 0.43 respectively), 
whereas amixture of the Harderoporphyrin and the 
synthetic 2-vinylporphyrin tricarboxylic acid did not 
show any evidence of separation after a similar distri- 
bution. 
Harderoporphyrin sthus clearly shown to be 4,6, 
7-tri(2carboxyethyl)-l,3,5,8-tetramethyl-2-vinylpor- 
phyrin (Ia). The relatively large amount found in the 
glands is of considerable interest in relation to the 
biogenesis of protoporphyrin and it seems likely that 
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HOzCCHzCHz CHzCH*COaH Me02CCHzCH2 CHzCHzCOzMe 
I a) Rr = CH=CHz II a) Rr = CH2CH20Ac 
Rz = CH2CH2C02H R2 = CH2CHzC02Me 
b) R’ = CH2CH2C02H Rr = CH2CHaC02Me 
R2 = CH=CH2 Ra = CHaCH20Ac 
the Harderian porphyrin is formed by dehydrogena- 
tion of an intermediate in the conversion of copropor- 
phyrinogen-III to protoporphyrinogen-IX [ 1 I] . If this 
is so, modification of the 2-propionic acid (in copro- 
porphyrinogen) precedes that of the 4-propionic acid 
in the biosynthetic sequence. The reason for the greater 
reactivity of the 2-propionate group may perhaps be 
deduced from the relative rates of enzymic decarbox- 
ylation of the coproporphyrinogen isomers [121 ;
types I and II are inert, whereas type IV decarbox- 
ylates at one tenth the rate of type III. If vicinal pro- 
pionate groups are essential for binding of the enzyme, 
then type I cannot bind, and in type II there are two 
pairs of vi&al propionate groups but decarboxylation 
of any one propionate is likely to be hindered by in- 
teraction with its neighbour. In type IV both the l- 
and 4-propionate groups are in the same relative orien- 
tation to the vicinal propionate groups (at positions 6 
and 7) as is the 4propionate group of type III. There- 
fore, as type III is known to be decarboxylated more 
rapidly than type IV, it is the 2-propionate which is 
degraded the faster. It is perhaI;s ignificant that in two 
porphyrins from other mammalian sources, pempto- 
porphyrin [ 10,131 (I,R1 = H,R2 = CH:CH,) and 
chlorocruoroporphyrin [ 10,141 (I,R1 = CH0,R2 = 
CH:CH2) the group in the 2-position has been even 
further degraded. It will be interesting to discover 
whether the porphyrin, recently isolated from meco- 
mum [ 151 and shown by mass pectrometry t to be a 
dehydrocoproporphyrin, has an acrylic acid side-chain 
t Mass spectrum determined at Liverpool with an A.E.I. MS9 
spectrometer. 
Me-Me II 
PhCHz02C CONMe 
also at the 2-position. The relatively large accumula- 
tion of free porphyrins in the Harderian gland (rather 
than haem) is presumably due to the lack of an iron- 
chelating enzyme. 
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